230
Participants
Start Date
November 20, 2024
Primary Completion Date
October 31, 2027
Study Completion Date
December 31, 2027
TORL-1-23
2.4mg/kg intravenous infusion on Day 1 of every 3-week cycle.
TORL-1-23
3.0 mg/kg intravenous infusion on Day 1 of every 3-week cycle.
TORL-1-23
3.4 mg/kg intravenous infusion on Day 1 of every 3-week cycle.
Pegfilgrastim (drug)
6.0 mg subcutaneous injection on Day 4 of each cycle.
RECRUITING
Blacktown Hospital, Blacktown
RECRUITING
UZ Leuven, Leuven
RECRUITING
Flinders Medical Centre, Bedford Park
RECRUITING
Universitatsklinik Innsbruck, Innsbruck
RECRUITING
SCRI - Alliance Cancer Specialists, PC, Doylestown
RECRUITING
Humanitas San Pio X, Milan
RECRUITING
SCRI - Maryland Oncology Hematology, P.A., Annapolis
RECRUITING
SCRI - Virginia Oncology Associates, Norfolk
RECRUITING
Duke Cancer Center, Durham
RECRUITING
Winship Cancer Institute, Emory University, Atlanta
RECRUITING
Mayo Clinic Florida, Jacksonville
RECRUITING
The James Cancer Hospital and Solove Research Institute - Ohio State University, Columbus
RECRUITING
SCRI - Minnesota Oncology Hematology, P.A., Minneapolis
RECRUITING
University of Minnesota, Minneapolis
RECRUITING
Mayo Clinic, Rochester
RECRUITING
University of Chicago Medical Center, Chicago
RECRUITING
Washington University, St Louis
RECRUITING
Stephenson Cancer Center at the University of Oklahoma, Oklahoma City
RECRUITING
SCRI - Texas Oncology, Fort Worth
RECRUITING
Mayo Clinic Hospital, Phoenix
RECRUITING
SCRI - Arizona Oncology Associates, PC-HOPE, Tucson
RECRUITING
UCLA - JCCC Clinical Research Unit, Los Angeles
RECRUITING
City of Hope National Medical Center, Duarte
RECRUITING
SCRI - Sansum Clinic, Santa Barbara
RECRUITING
SCRI - Northwest Cancer Specialists, P.C., Portland
RECRUITING
National University Cancer Institute, Singapore
RECRUITING
National Cancer Centre, Singapore
RECRUITING
Curie Oncology (Farrer), Singapore
RECRUITING
Smilow Cancer Hospital at Yale - New Haven, New Haven
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Rutgers Cancer Institute, New Brunswick
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
Monash Medical Centre, Clayton
RECRUITING
Icon Cancer Centre Chermside, Chermside
RECRUITING
Linear Clinical Research, Perth
RECRUITING
British Columbia Cancer Agency (BC Cancer, part of the Provincial Health Services Authority), Vancouver
RECRUITING
Sunnybrook Research Institute, Toronto
RECRUITING
Princess Margaret Cancer Centre - University Health Network (UHN), Toronto
RECRUITING
Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal
RECRUITING
Sir Mortimer B. Davis Jewish General Hospital, Montreal
RECRUITING
McGill University Health Centre (MUHC) - Royal Victoria Hospital, Montreal
RECRUITING
Start Dublin - Mater Misericordiae University Hospital, Dublin
European Network of Gynaecological Oncological Trial Groups (ENGOT)
OTHER
TORL Biotherapeutics, LLC
INDUSTRY